Glycosensors and Diagnostics
Industry: Reagents for glycomics analysis and research
Glycosensors and Diagnostics has developed advanced computational methods to aid in glycoscience research.
Using its advanced computational simulations, the company is developing carbohydrate-based therapeutics and reagents that support the needs of glycoscience researchers. The company’s technology includes custom-engineered glycan-binding proteins as well as platforms to profile and analyze glycoproteins and glycan-binding proteins.
The company has partnered with the International AIDS Vaccine Initiative and GlycoMimetics, Inc. to develop an AIDS vaccine made from compounds that mimic carbohydrates.
Company website: Glycosensors and Diagnostics